EUVIMEDEUVIMED entdecken
Fallbericht

Living Donor Liver Transplantation for Congenital Portosystemic Shunt Presenting With Hyperinsulinemic Hypoglycemia

Masashi Kadohisa iD, Tatsuya Okamoto iD, Kougorou Iwanaga, Miki Yamamoto, Elena Yukie Uebayashi, Eri Ogawa, Hideaki Okajima, Etsuro Hatano

Pediatric Transplantation · 2024

DOI: 10.1111/petr.14871 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Pediatric Transplantation, 2024. Verfasst von Masashi Kadohisa und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Kyoto University Graduate School of Medicine, Kyoto, Japan. Hauptthemen laut MEDLINE: Liver Transplantation, Living Donors, Portal Vein, Hyperinsulinism. Die Arbeit nennt 18 Literaturangaben. Gefördert von: Research on rare and intractable disease, Health Labour Science Research Grant, Japan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

A congenital portosystemic shunt (CPSS) is defined as abnormal vascular communications between the portal vein and the systemic vein. Encephalopathy, hepatopulmonary syndrome, and portopulmonary hypertension are manifestations in patients with CPSS. Hyperinsulinemic hypoglycemia is also one of the manifestations of CPSS. Hyperinsulinemic hypoglycemia secondary to CPSS is caused by a lack of hepatic first‐pass elimination of insulin, which is secreted from pancreatic beta cells. Case Presentation A 7‐month‐old boy had hypergalactosemia detected by newborn mass screening. Enhanced abdominal computed tomography showed the absence of the portal vein trunk and extrahepatic portosystemic communication between the superior mesenteric vein and the inferior vena cava. He had suffered from uncontrollable hyperinsulinemic hypoglycemia under protein and lactose restriction. We performed living donor liver transplantation (LDLT) using a left lateral segment graft from his father. The postoperative course was uneventful and the hypoglycemic attacks disappeared.

Conclusion

We believe that uncontrolled hyperinsulinemic hypoglycemia secondary to CPSS is an indication of LDLT.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver TransplantationLiving DonorsPortal VeinHyperinsulinismHypoglycemiaHumansMaleInfantVascular MalformationsCongenital Hyperinsulinism

Stichwörter der Autor:innen

hyperinsulinemic hypoglycemialiver transplantationportosystemic shunt

Autor:innen und Institutionen

  • Department of Surgery, Kyoto University Graduate School of Medicine, Kyoto, Japan.
  • Department of Pediatric Surgery, Kyoto University Hospital, Kyoto, Japan.
  • Department of Pediatrics, Kyoto University Graduate School of Medicine, Kyoto, Japan.
  • Department of Pediatric Surgery, Kanazawa Medical University, Kanazawa, Japan.
  • Department of Hepato-Biliary-Pancreatic Surgery and Transplantation, Kyoto University Hospital, Kyoto, Japan.

ORCID-Profile: Masashi Kadohisa, Tatsuya Okamoto

Förderung

  • Research on rare and intractable disease, Health Labour Science Research Grant, Japan

Zitieren

APA

Kadohisa, M., Okamoto, T., Iwanaga, K., Yamamoto, M., Uebayashi, E. Y., Ogawa, E., Okajima, H., & Hatano, E. (2024). Living Donor Liver Transplantation for Congenital Portosystemic Shunt Presenting With Hyperinsulinemic Hypoglycemia. Pediatric Transplantation. https://doi.org/10.1111/petr.14871

Vancouver

Kadohisa M, Okamoto T, Iwanaga K, Yamamoto M, Uebayashi EY, Ogawa E, et al. Living Donor Liver Transplantation for Congenital Portosystemic Shunt Presenting With Hyperinsulinemic Hypoglycemia. Pediatric Transplantation. 2024. doi:10.1111/petr.14871

BibTeX
@article{Kadohisa2024,
  author = {Kadohisa, Masashi and Okamoto, Tatsuya and Iwanaga, Kougorou and Yamamoto, Miki and Uebayashi, Elena Yukie and Ogawa, Eri and Okajima, Hideaki and Hatano, Etsuro},
  title = {Living Donor Liver Transplantation for Congenital Portosystemic Shunt Presenting With Hyperinsulinemic Hypoglycemia},
  journal = {Pediatric Transplantation},
  year = {2024},
  doi = {10.1111/petr.14871}
}
Kostenlos starten →